tiprankstipranks
Advertisement
Advertisement
Ro Highlights Structural Shifts in Healthcare Driven by GLP-1 Demand
PremiumPrivate CompaniesRo Highlights Structural Shifts in Healthcare Driven by GLP-1 Demand
17d ago
Ro Positions Around GLP-1 Demand and Evolving Patient-Centered Care
Premium
Private Companies
Ro Positions Around GLP-1 Demand and Evolving Patient-Centered Care
17d ago
Ro Expands GLP-1 Offering With Addition of Eli Lilly’s Foundayo Pill
Premium
Private Companies
Ro Expands GLP-1 Offering With Addition of Eli Lilly’s Foundayo Pill
24d ago
Ro Expands Wegovy Pricing Discounts and Ties Savings to Upcoming Membership Program
PremiumPrivate CompaniesRo Expands Wegovy Pricing Discounts and Ties Savings to Upcoming Membership Program
1M ago
Ro Deepens Novo Nordisk Partnership With Lower-Cost Wegovy Plans and Expanded GLP-1 Offering
Premium
Private Companies
Ro Deepens Novo Nordisk Partnership With Lower-Cost Wegovy Plans and Expanded GLP-1 Offering
1M ago
Ro Expands GLP-1 Access With Wegovy Pricing and Membership Savings Focus
Premium
Private Companies
Ro Expands GLP-1 Access With Wegovy Pricing and Membership Savings Focus
1M ago
Ro Partners with Amgen to Use Real-World Data to Tackle GLP-1 Access Barriers in Obesity Care
PremiumPrivate CompaniesRo Partners with Amgen to Use Real-World Data to Tackle GLP-1 Access Barriers in Obesity Care
4M ago
Ro Becomes Key Direct-to-Patient Channel for Novo Nordisk’s New Oral Wegovy Launch
Premium
Private Companies
Ro Becomes Key Direct-to-Patient Channel for Novo Nordisk’s New Oral Wegovy Launch
4M ago
Ro’s Telehealth Platform Achieves Significant Weight Loss in Semaglutide Study
Premium
Private Companies
Ro’s Telehealth Platform Achieves Significant Weight Loss in Semaglutide Study
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100